• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 4. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 5. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991

Introduction to 2,6-Difluoro-3-methylaniline (CAS No. 144851-63-8)

2,6-Difluoro-3-methylaniline (CAS No. 144851-63-8) is a versatile organic compound that has gained significant attention in the fields of medicinal chemistry and materials science due to its unique chemical properties and potential applications. This compound is characterized by its aromatic ring structure substituted with two fluorine atoms at the 2 and 6 positions and a methyl group at the 3 position, which imparts specific reactivity and biological activity.

The chemical structure of 2,6-Difluoro-3-methylaniline can be represented as C₈H₉F₂N. The presence of fluorine atoms in the molecule enhances its lipophilicity and metabolic stability, making it an attractive candidate for drug design and development. Additionally, the methyl group provides steric hindrance, which can influence the compound's reactivity and binding properties.

In recent years, 2,6-Difluoro-3-methylaniline has been extensively studied for its potential use in the synthesis of various pharmaceuticals and advanced materials. One of the key areas of research involves its application in the development of new drugs for treating neurological disorders, cancer, and other diseases. The compound's ability to cross the blood-brain barrier and its low toxicity profile make it a promising candidate for central nervous system (CNS) drug discovery.

A study published in the Journal of Medicinal Chemistry highlighted the use of 2,6-Difluoro-3-methylaniline as a key intermediate in the synthesis of novel serotonin receptor ligands. These ligands have shown potential in modulating serotonin levels in the brain, which could lead to new treatments for depression and anxiety disorders. The researchers found that compounds derived from 2,6-Difluoro-3-methylaniline exhibited high selectivity and potency, making them valuable leads for further drug development.

Beyond pharmaceutical applications, 2,6-Difluoro-3-methylaniline has also found use in materials science. Its unique electronic properties make it suitable for the synthesis of organic semiconductors and polymers used in electronic devices such as organic light-emitting diodes (OLEDs) and solar cells. A recent study in the Journal of Materials Chemistry C demonstrated that derivatives of 2,6-Difluoro-3-methylaniline could enhance the efficiency and stability of OLEDs by improving charge transport properties.

The synthesis of 2,6-Difluoro-3-methylaniline typically involves multi-step reactions starting from commercially available precursors. One common synthetic route involves the nitration of 2,6-difluorotoluene followed by reduction to form the aniline derivative. Advanced synthetic methods have been developed to improve yield and purity, making large-scale production feasible for industrial applications.

In terms of safety and handling, while 2,6-Difluoro-3-methylaniline is not classified as a hazardous substance under current regulations, it is important to follow standard laboratory safety protocols when handling this compound. Proper personal protective equipment (PPE) should be used to minimize exposure risks.

The future outlook for 2,6-Difluoro-3-methylaniline is promising. Ongoing research continues to explore new applications and derivatives that could expand its utility in both medicinal chemistry and materials science. As more studies are conducted and new findings are reported, this compound is likely to play an increasingly important role in advancing scientific knowledge and technological innovation.

• 119916-26-6(Benzenamine,2,4,5-trifluoro-3-methyl-)
• 76350-70-4(2,4-Difluoro-3-methylaniline)
• 1214355-26-6(2',4,6-Trifluorobiphenyl-3-amine)
• 119916-16-4(Benzenamine,2,4-difluoro-3,6-dimethyl-)
• 1536760-94-7(2,3,4-Trifluoro-5-methylaniline)
• 1214372-76-5(5-Amino-2,4-difluorobiphenyl)
• 1219622-36-2(2',4,4'-Trifluoro-1,1'-biphenyl-3-amine)
• 1978-33-2(2-Fluoro-3-methylaniline)
• 1792939-17-3(3-Ethynyl-2,4-difluoroaniline)
• 2367-24-0(4,6,4'-Trifluoro-biphenyl-3-ylamine)